How rare diseases are shaping therapeutic innovation with Jennifer Adair, Claire Booth,Terry Flotte and Donald Kohn

This episode, recorded at the ASGCT 2026 Annual Meeting in Boston, focuses on *Molecular Therapy Advances*’ upcoming special issue, Beyond prevalance: How rare diseases are reshaping therapeutic innovation. Listen as Editor-in-Chief of *Molecular Therapy Advances,* Dr. Mohamed Abou-el-Enein, discusses the evolution of therapeutic development for rare diseases with guest editors Drs. Jennifer Adair, Claire Booth, Terence Flotte, and Donald Kohn. **Music:** 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au Show your support for ASGCT!: https://asgct.org/membership/donate See omnystudio.com/listener for privacy information.